BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Thermo Fisher Scientific Expands PPD Laboratory Services Network With New Bioanalytical Facility In Sweden

The state-of-the-art facility enhances support for complex modalities across all phases of drug development Key facts Thermo Fisher opens new bioa...

May 19, 2026 | News

ImmunityBio Secures Exclusive US Rights To Tokyo Strain BCG To Address Chronic Bladder Cancer Treatment Shortage

Positive Phase III readout of National Cancer Institute sponsored SWOG S1602 randomized clinical trial demonstrating non-inferior efficacy of the Tokyo...

May 19, 2026 | News

SN BioScience Inc. Initiates Global Phase 1b/2 Trial Of SNB 101 In Extensive Stage Small Cell Lung Cancer

SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its...

May 18, 2026 | News

Akeso, Inc. Highlights Promising Phase II AML Data For Ligufalimab Combination At EHA 2026

Akeso, Inc. announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will ...

May 18, 2026 | News

Racura Oncology Receives Positive Safety Review Committee Recommendation To Advance CPACS Trial In Advanced Solid Tumours

Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced soli...

May 18, 2026 | News

Corti Launches Global Healthcare AI Startup Program Amid Rising Regulatory Pressure Across Europe And The US

As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 r...

May 15, 2026 | News

Suzhou Ribo Life Science And Insilico Medicine Forge Strategic Alliance To Accelerate AI Powered siRNA Drug Development

Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Me...

May 14, 2026 | News

Curocell And ProBio Achieve Korean Milestone With Approval Of Next Generation CAR T Therapy Anbal cel

Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene th...

May 13, 2026 | News

Hengrui Pharma And Bristol Myers Squibb Forge $15.2 Billion Strategic Alliance Across Oncology And Immunology

Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreement...

May 13, 2026 | News

ACROBiosystems Expands Global Licensing Access For HEK293 Functional Cell Lines

ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global ...

May 12, 2026 | News

Chance Pharma Advances First NDA Submission In China For Innovative Asthma Therapy CXG87

Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhala...

May 11, 2026 | News

Rznomics Secures FDA RMAT Designation For RNA Editing Therapy RZ 001 In Liver Cancer

RMAT designation based on promising Phase 1b/2a clinical data, including safety profile and preliminary response rates, ...

May 11, 2026 | News

Harbour BioMed Secures US FDA Clearance For Phase I Trial Of Bispecific Cancer Antibody HBM7004

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics i...

May 11, 2026 | News

ACROBiosystems Simplifies Global HEK293 Licensing To Accelerate Biopharma R&D Compliance

ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrat...

May 11, 2026 | News

Stay Connected